Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China flag China · Delayed Price · Currency is CNY
29.59
-0.69 (-2.28%)
Feb 2, 2026, 4:00 PM EST

SHA:603207 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
504.23474.23471.56456.46401.29360.59
Other Revenue
0.360.360.310.430.480.65
504.59474.58471.87456.89401.77361.23
Revenue Growth (YoY)
6.89%0.57%3.28%13.72%11.22%6.37%
Cost of Revenue
170.02163.28163.07187.44147.34132.57
Gross Profit
334.57311.3308.8269.45254.43228.67
Selling, General & Admin
74.3360.5759.4754.6595.0640.03
Research & Development
13.5615.1116.2813.5814.211.36
Other Operating Expenses
3.611.912.443.012.15
Operating Expenses
92.5277.8178.3373.6111.5953.49
Operating Income
242.05233.49230.48195.85142.84175.18
Interest Expense
-0.01-0.03-0.05-0.07-0.09-
Interest & Investment Income
7.026.073.763.813.123.84
Other Non Operating Income (Expenses)
0.73-0.03-0.05-0.04-0.01-0.03
EBT Excluding Unusual Items
249.79239.5234.14199.55145.85178.98
Gain (Loss) on Sale of Investments
--0.060.010.050.13
Gain (Loss) on Sale of Assets
---0-0.25
Asset Writedown
-0.13----0.01-
Other Unusual Items
-0.610.012.976.498.667.52
Pretax Income
249.05239.51237.17206.06154.55186.88
Income Tax Expense
35.5634.2433.5430.8828.2826.95
Net Income
213.5205.27203.63175.18126.27159.93
Net Income to Common
213.5205.27203.63175.18126.27159.93
Net Income Growth
8.50%0.81%16.24%38.74%-21.05%12.67%
Shares Outstanding (Basic)
160134120120120-
Shares Outstanding (Diluted)
161134120120120-
Shares Change (YoY)
29.43%12.01%-0.17%-0.22%--
EPS (Basic)
1.341.531.701.461.05-
EPS (Diluted)
1.331.531.701.461.05-
EPS Growth
-16.17%-10.00%16.44%39.05%--
Free Cash Flow
112.9128.27120.1175.61167.03138.51
Free Cash Flow Per Share
0.700.961.000.631.39-
Dividend Per Share
2.2001.500----
Gross Margin
66.31%65.59%65.44%58.97%63.33%63.30%
Operating Margin
47.97%49.20%48.84%42.86%35.55%48.49%
Profit Margin
42.31%43.25%43.15%38.34%31.43%44.27%
Free Cash Flow Margin
22.38%27.03%25.45%16.55%41.57%38.34%
EBITDA
244.12235.89233.3199.08146.45179.26
EBITDA Margin
48.38%49.70%49.44%43.57%36.45%49.62%
D&A For EBITDA
2.082.42.833.243.614.08
EBIT
242.05233.49230.48195.85142.84175.18
EBIT Margin
47.97%49.20%48.84%42.86%35.55%48.49%
Effective Tax Rate
14.28%14.29%14.14%14.99%18.30%14.42%
Revenue as Reported
504.59474.58471.87---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.